CliffBio
small molecule

LORATADINE

LORATADINE

Loss of exclusivity—loss of exclusivity
CompanyTaro Pharmaceutical Industries →See this company's full patent-cliff portfolio

Drug detail

Brand nameLORATADINE
Active ingredientLORATADINE
Strength1MG/ML
Dosage formSYRUP
RouteORAL
ModalitySmall molecule
FDA approvalAugust 2004
Marketing statusOTC

More from Taro Pharmaceutical Industries

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.